Logo image of CPTN

CEPTON INC (CPTN) Stock Fundamental Analysis

NASDAQ:CPTN - US15673X2009 - Common Stock

3.25 USD
+0.07 (+2.12%)
Last: 1/6/2025, 8:00:00 PM
Fundamental Rating

4

Taking everything into account, CPTN scores 4 out of 10 in our fundamental rating. CPTN was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. While CPTN has a great health rating, there are worries on its profitability. CPTN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CPTN had negative earnings in the past year.
In the past year CPTN has reported a negative cash flow from operations.
In the past 5 years CPTN reported 4 times negative net income.
CPTN had a negative operating cash flow in each of the past 5 years.
CPTN Yearly Net Income VS EBIT VS OCF VS FCFCPTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -45.65%, CPTN is not doing good in the industry: 84.30% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -61.87%, CPTN is doing worse than 80.17% of the companies in the same industry.
Industry RankSector Rank
ROA -45.65%
ROE -61.87%
ROIC N/A
ROA(3y)-86.79%
ROA(5y)-60.13%
ROE(3y)61.12%
ROE(5y)27.65%
ROIC(3y)N/A
ROIC(5y)N/A
CPTN Yearly ROA, ROE, ROICCPTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 200 -200 400

1.3 Margins

CPTN's Gross Margin of 52.55% is amongst the best of the industry. CPTN outperforms 90.08% of its industry peers.
The Profit Margin and Operating Margin are not available for CPTN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CPTN Yearly Profit, Operating, Gross MarginsCPTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

7

2. Health

2.1 Basic Checks

CPTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CPTN has more shares outstanding than it did 1 year ago.
CPTN has less shares outstanding than it did 5 years ago.
There is no outstanding debt for CPTN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CPTN Yearly Shares OutstandingCPTN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M
CPTN Yearly Total Debt VS Total AssetsCPTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

CPTN has an Altman-Z score of -2.03. This is a bad value and indicates that CPTN is not financially healthy and even has some risk of bankruptcy.
CPTN has a Altman-Z score of -2.03. This is amonst the worse of the industry: CPTN underperforms 87.60% of its industry peers.
CPTN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.03
ROIC/WACCN/A
WACC8.7%
CPTN Yearly LT Debt VS Equity VS FCFCPTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 5.52 indicates that CPTN has no problem at all paying its short term obligations.
CPTN has a better Current ratio (5.52) than 85.95% of its industry peers.
A Quick Ratio of 5.41 indicates that CPTN has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.41, CPTN belongs to the top of the industry, outperforming 87.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.52
Quick Ratio 5.41
CPTN Yearly Current Assets VS Current LiabilitesCPTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.43% over the past year.
CPTN shows a strong growth in Revenue. In the last year, the Revenue has grown by 84.44%.
Measured over the past years, CPTN shows a very strong growth in Revenue. The Revenue has been growing by 86.58% on average per year.
EPS 1Y (TTM)50.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.82%
Revenue 1Y (TTM)84.44%
Revenue growth 3Y86.58%
Revenue growth 5YN/A
Sales Q2Q%-85.73%

3.2 Future

The Earnings Per Share is expected to grow by 27.17% on average over the next years. This is a very strong growth
Based on estimates for the next years, CPTN will show a very strong growth in Revenue. The Revenue will grow by 134.57% on average per year.
EPS Next Y33.68%
EPS Next 2Y29.56%
EPS Next 3Y15.7%
EPS Next 5Y27.17%
Revenue Next Year74.25%
Revenue Next 2Y56.91%
Revenue Next 3Y118.4%
Revenue Next 5Y134.57%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CPTN Yearly Revenue VS EstimatesCPTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
CPTN Yearly EPS VS EstimatesCPTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CPTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CPTN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CPTN Price Earnings VS Forward Price EarningsCPTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CPTN Per share dataCPTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as CPTN's earnings are expected to grow with 15.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.56%
EPS Next 3Y15.7%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CPTN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CEPTON INC

NASDAQ:CPTN (1/6/2025, 8:00:00 PM)

3.25

+0.07 (+2.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners9.94%
Inst Owner Change0%
Ins Owners48.98%
Ins Owner Change0%
Market Cap52.16M
Analysts47.5
Price Target8.76 (169.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.45%
Min EPS beat(2)-98.8%
Max EPS beat(2)81.9%
EPS beat(4)3
Avg EPS beat(4)12.58%
Min EPS beat(4)-98.8%
Max EPS beat(4)81.9%
EPS beat(8)7
Avg EPS beat(8)11.48%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-44.28%
Min Revenue beat(2)-81.51%
Max Revenue beat(2)-7.06%
Revenue beat(4)1
Avg Revenue beat(4)-11.97%
Min Revenue beat(4)-81.51%
Max Revenue beat(4)97.33%
Revenue beat(8)2
Avg Revenue beat(8)-16.74%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.4%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-26.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.92
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)-1.74
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS1.11
BVpS2.92
TBVpS2.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.65%
ROE -61.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.55%
FCFM N/A
ROA(3y)-86.79%
ROA(5y)-60.13%
ROE(3y)61.12%
ROE(5y)27.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.17%
Cap/Sales 0.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.52
Quick Ratio 5.41
Altman-Z -2.03
F-Score5
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)205.78%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.78%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.82%
EPS Next Y33.68%
EPS Next 2Y29.56%
EPS Next 3Y15.7%
EPS Next 5Y27.17%
Revenue 1Y (TTM)84.44%
Revenue growth 3Y86.58%
Revenue growth 5YN/A
Sales Q2Q%-85.73%
Revenue Next Year74.25%
Revenue Next 2Y56.91%
Revenue Next 3Y118.4%
Revenue Next 5Y134.57%
EBIT growth 1Y43.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.17%
EBIT Next 3Y19.51%
EBIT Next 5Y35.31%
FCF growth 1Y83.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.83%
OCF growth 3YN/A
OCF growth 5YN/A